PositiveID to debut new biosensor

A subsidiary of PositiveID Corporation, a medical device and diagnostic developer, announced on Tuesday that it will present its Microfluidics-based Bioagent Autonomous Networked Detector system at a biodefense research meeting in February in Washington D.C.

MicroFluidic Systems will present the M-BAND system at the 10th Annual American Society for Microbiology Biodefense and Emerging Diseases Research Meeting, which will be held at the Omni Shoreham Hotel between February 26 and February 29. The company will jointly exhibit the system with Hamilton Sundstrand and the Boeing Company.

M-BAND was developed by MFS under a contract with the Department of Homeland Security. The detector is an early warning system that is built to detect the intentional release of biological agents that have been aerosolized. The system runs autonomously for as many as 30 days while analyzing air continuously for the detection of toxins, viruses and bacteria. The device, used typically in high-traffic areas, can provide results in as little as three hours.

The results from instruments in the M-BAND system are in reported in real time via a secure wireless network to give an up to date and accurate status. The system can be used to detect for RNA-based organisms, DNA-based pathogens, toxins or all three simultaneously.

During the conference, approximately 1,000 decision makers and leaders in the biodefense fields will discuss the critical research necessary to shape the future of biodefense.

Organizations in this story

The Boeing Company 100 N Riverside Plaza Chicago, IL 60606

American Society for Microbiology 1752 N St NW Washington, DC 20036

Get notified the next time we write about any of these organizations